首页> 外国专利> A conjugated polymer of 20 - 0 - - Aminoacyl glycyl glycyl camptothecin, a procedure for producing such conjugated Polymer, a Derivative of 20 - 0 - acylamino - glycyl - camptothecin,A Derivative of 20 - 0 - - - (metacriloil glycyl glycyl - Aminoacyl) camptothecin Derivatives, processes for producing these

A conjugated polymer of 20 - 0 - - Aminoacyl glycyl glycyl camptothecin, a procedure for producing such conjugated Polymer, a Derivative of 20 - 0 - acylamino - glycyl - camptothecin,A Derivative of 20 - 0 - - - (metacriloil glycyl glycyl - Aminoacyl) camptothecin Derivatives, processes for producing these

机译:20-0-[]-氨酰基缩水甘油基喜树碱的共轭聚合物,制备这种共轭聚合物的方法,20-0-酰氨基-甘氨酰-喜树碱的衍生物,20-0---([metacriloil glycyl甘氨酰-氨基酰基)]喜树碱衍生物及其制备方法

摘要

A conjugated polymer of [0 - 20 - camptothecin glycyl glycyl - Aminoacyl] consisting of: (i) between 85 and 97 mol% units of N - (2-hydroxypropyl) represented by the formula (3 metacriloilamida; (i)(i) between 3 and 15 mol% of unidadesd and 20 - 0 - (N - glycyl glycyl - metacriloil - Aminoacyl) - camptotecinarepresentadas BY FORMULA (4), in which n is between 2 and 8- [CPT] represents the residue of a camptothecin of formula (2), which is the encuentraunida c-20 position Q and the EU each R1, R2, R3, R4 and R5 can be equal or different,Is Hydrogen, C1 - 12 oramificado linear alkyl, Nitro, amino, (CH2) anr6r7, which ranges between 0 and 4 and R6 and R7 are Hydrogen or a hydrogen between R6 and R7 is the Mong and R6 and R7 is alquiloc1 - 6Or nr6r7 represents a Ring of N - alkyl - or piperazino piperazino optionally replaced with linear or branched alkyl C1 - 6 or a piperidino ring,Anhcor8 (CH2) where a is defined as before, and R8 is C1 - 8 linear or branched alkyl group or a nr6r7 as mentioned before, Hydroxy or co - R8,Where R8 is as defined before or represents a 1 - 1.4 - piperidino Ring or bipiperidino R2 and R3, or taken in formaconjunta represents the residue of N, o - (CH2) B - or,Where B is 1 or 2; R4 and R5 represents the residue of (CH2) m, where M is between 2 and 4The residuoch2 CH2 or - or - or ch2nhch2; and (iii) between 0 and 12 mol% units of metacriloil Glycine N - or N - (2 - hydroxy - propyl) - metacriloil glycinamide representadaspor formula (5),In the [z] represents a Hydroxy group or a residue of the Formula - NH - CH2 CH (OH) - CH3.This conjugated Polymer has a actividadantitumoralmejorada and reduced toxicity compared with the free Drug. A procedure to produce this conjugated Polymer, a Derivative of
机译:一种[0-20-喜树碱糖基缩水甘油基-氨基酰基]的共轭聚合物,其由以下组成:(i)85-97 mol%的由式(3 cri)表示的N-(2-羟丙基)单元;(i)(i)式(4)表示3至15 mol%的单酸酯和20-0-(N-甘氨酰甘氨酰-甲基丙烯酰-氨基酰基)-camptotecinarepresentadas,其中n为2至8。[CPT]代表喜树碱的残基式(2),即encuentraunida c-20位置Q和EU上的R1,R2,R3,R4和R5可以相同或不同,是氢,C1-12 oramificado直链烷基,硝基,氨基(CH2) anr6r7,其范围介于0和4之间,R6和R7是氢或R6和R7之间的氢是Mong且R6和R7是alquiloc1-6或nr6r7代表N-烷基或哌嗪子基哌嗪子环,可选用直链或支链取代烷基C1-6或哌啶子基环,Anhcor8(CH2),其中a的定义如前,R8为C1-8直链或支链的烷基或nr6r7之前提及的是羟基或共-R 8,其中R 8如前所定义或代表1-1.4-哌啶子基环或双哌啶子基R 2和R 3,或在甲结中表示N,o-(CH 2)B-或的残基,其中B是1或2; R 4和R 5表示(CH 2)m的残基,其中M在2-4之间。残基CH 2或-或-或ch 2 nhch 2; (iii)在0至12 mol%单元之间的间苯三酚甘氨酸N-或N-(2-羟基-丙基)-间苯三酚甘氨酰胺代表式(5),在[z]中代表羟基或该式的残基-NH-CH2 CH(OH)-CH3。与游离药物相比,这种共轭聚合物具有actividadantitumoralmejorada和降低的毒性。该共轭聚合物的衍生物的制备方法

著录项

  • 公开/公告号AR013535A1

    专利类型

  • 公开/公告日2000-12-27

    原文格式PDF

  • 申请/专利权人 PHARMACIA & UPJOHN S.P.A.;

    申请/专利号AR1998P104876

  • 发明设计人

    申请日1998-09-30

  • 分类号A61K31/4745;A61K31/74;A61K47/48;A61P35/00;C07D491/22;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号